Published trade mark details for 2587920

This information was published on 2025-12-02T11:24:27 for IP Right Registration Published.

Field	Value
(210)	2587920 (IR 1876417)
(220)	29 Jul 2025
(300)	US, 29 Jan 2025, 99022541
(500)	The mark consists of the stylized wording RINGTX.
(511) (510)	Class 5 Encapsulated nucleic acids for use as biological therapeutics in gene therapy for the treatment of human diseases and disorders; pharmaceutical preparations for use in gene therapy for the treatment of rare genetic disorders, cardiovascular diseases, respiratory diseases, infectious diseases, retinal diseases, metabolic disorders, hormonal deficiencies, endocrine diseases, eye diseases and disorders, intestinal diseases, autoimmune diseases, autoinflammatory diseases, inflammatory disorders, musculoskeletal diseases, neurological disorders, hematologic conditions, cutaneous conditions, neurodegenerative diseases, congenital disorders, kidney and urinary diseases, reproductive diseases, mitochondrial diseases, lung disorders, immune system diseases, mouth diseases, digestive diseases. Class 40 Custom manufacture of anelloviruses.
(540)
(730)	Ring Therapeutics, Inc.

 

Find out more about publications on the About page.